Also trades as: EYE.AX (ASX) · $vol 0M
ELXMF OTC
Nova Eye Medical Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +653.2%
1Y: -85.7%
3Y: -85.7%
5Y: -94.5%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$3M
+49.3% ▲
Capital Expenditures
$235K
+21.3% ▲
5Y CAGR: -36.2%
Free Cash Flow
-$3M
+48.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$4M
-250.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$7M | -$15M | -$9M | -$9M | -$4M |
| Depreciation & Amort. | $2M | $2M | $3M | $2M | $2M |
| Stock-Based Comp. | $203K | $178K | $0 | $89K | $0 |
| Change in Working Capital | $2M | $191K | -$2M | $690K | -$892K |
| Other Non-Cash Items | $521K | $10M | $1K | -$132K | -$63K |
| Operating Cash Flow | -$5M | -$7M | -$8M | -$6M | -$3M |
| — Investing Activities — | |||||
| Capital Expenditures | -$6M | -$800K | -$211K | -$298K | -$387K |
| Acquisitions (Net) | $1M | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | -$114K | -$66K | $0 |
| Investing Cash Flow | -$5M | -$800K | -$325K | -$364K | -$387K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$402K | -$653K | -$518K | -$613K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $6M | -$656K |
| Financing Cash Flow | -$402K | $7M | $7M | $6M | -$656K |
| Net Change in Cash | -$10M | -$581K | -$1M | -$1M | -$4M |
| Cash End of Period | $8M | $7M | $6M | $5M | $963K |
| Free Cash Flow | -$10M | -$8M | -$8M | -$6M | -$3M |